Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Published August 22, 2018 · Recall initiated: August 9, 2018
Summary
FDA records drug Class III recall D-1099-2018, published August 22, 2018 and initiated August 9, 2018. Recalling firm: Orexigen Therapeutics, Inc.; Status: Terminated; Reported quantity: 95,296 bottles; Lot: Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Customer complaints of punctures in the bottle.
What to do
Voluntary: Firm initiated · Letter
Get an email if CONTRAVE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CONTRAVE
- Manufacturer
- Orexigen Therapeutics, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0351267890997
- Lot
- Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAContrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only,November 14, 2018
- FDAValsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, INAugust 22, 2018
- FDAValsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 KolterAugust 22, 2018
- FDAValsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals,August 22, 2018
- FDAValsartan 320 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 KolterAugust 22, 2018
- FDAPapav 300/Phent 5mg/10mL (Papaverine/Phentolamine) Injection,300 mg/5 mg/10 mL, 10 mL vial, Rx only, Ranier'sAugust 22, 2018
Questions about this recall
Was Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99. recalled?
Yes. FDA published recall D-1099-2018 on August 22, 2018. Reported hazard: Defective Container: Customer complaints of punctures in the bottle.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CONTRAVE. UPC: 0351267890997.